Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy

Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy

Bibliographic Details
Main Authors:	Jayaswal, A, Pavlides, M, Banerjee, R, Kelly, M, Barnes, E, Neubauer, S
Format:	Conference item
Published:	Wiley 2018

Similar Items

Liver cT1 predicts clinical outcomes in patients with chronic liver disease
by: Jayaswal, A, et al.
Published: (2019)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
by: Jayaswal, A, et al.
Published: (2020)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
by: Pavlides, M, et al.
Published: (2015)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
by: Pavlides, M, et al.
Published: (2016)

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?
by: Chin, J, et al.
Published: (2016)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
by: Jayaswal, ANA, et al.
Published: (2020)

Multi-parametric MRI predicts clinical outcomes in unselected patients with liver disease - a non-invasive test that meets the AASLD criteria for clinical trials?
by: Pavlides, M, et al.
Published: (2014)

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
by: Levick, C, et al.
Published: (2018)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
by: Pavlides, M, et al.
Published: (2014)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
by: Pavlides, M, et al.
Published: (2014)

Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases
by: Makoto Iijima, et al.
Published: (2021-01-01)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
by: Selvaraj, E, et al.
Published: (2019)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
by: Pavlides, M, et al.
Published: (2017)

From liver biopsy to non-invasive markers in evaluating fibrosis in chronic liver disease
by: Cătălina Diaconu, et al.
Published: (2015-08-01)

Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy
by: Nader Dbouk, et al.
Published: (2013-01-01)

THE DIAGNOSIS OF LIVER ALLOGRAFT ACUTE REJECTION IN LIVER BIOPSIES
by: L. V. Shkalova, et al.
Published: (2011-06-01)

The role of liver biopsy for asymptomatic liver enzyme elevation
by: Le Mire, M, et al.
Published: (2005)

CT-Based Radiomics Analysis to Predict Histopathological Outcomes Following Liver Resection in Colorectal Liver Metastases
by: Vincenza Granata, et al.
Published: (2022-03-01)

Transjugular liver biopsy
by: Antonio C. Maciel, et al.
Published: (2022-07-01)

Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy
by: Hesham Mohamed Atef, et al.
Published: (2023-12-01)

Interobserver variability in histologic evaluation of liver fibrosis using categorical and quantitative scores
by: Pavlides, M, et al.
Published: (2017)

Transjugular liver biopsy: enlarge the indications for liver biopsy with reliable diagnostic quality
by: Miao-Yang Chen, et al.
Published: (2023-08-01)

Predictive Power of Tissue and Circulating Biomarkers for the Severity of Biopsy-Validated Chronic Liver Diseases
by: Guido Bocci, et al.
Published: (2022-10-01)

A model for hepatic fibrosis: The competing effects of cell loss and iron on shortened Modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver
by: Tunnicliffe, E, et al.
Published: (2016)

Specific features of lymphoid infiltration in liver biopsy in patients with chronic viral hepatitis B and C
by: Karina Turakbaevna Umbetova, et al.
Published: (2011-11-01)

Evaluation of Liver Biopsy Results in Chronic Hepatitis B Patients
by: Nilgün Söğütçü, et al.
Published: (2020-09-01)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
by: Savic, D, et al.
Published: (2020)

Non-alcoholic fatty liver disease
by: Pavlides, M, et al.
Published: (2019)

Improving Medication‐Related Outcomes in Chronic Liver Disease
by: Kelly L. Hayward, et al.
Published: (2020-11-01)

Histologic Analysis of Transjugular Liver Biopsy Specimens for Early Prediction of Prognosis in Acute Liver Failure
by: Toru Ishikawa, et al.
Published: (2022-01-01)

The role of hepatic biopsy in liver graft evaluation during liver procurement
by: M. S. Novruzbekov, et al.
Published: (2016-12-01)

Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults
by: Hodson, L, et al.
Published: (2016)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
by: Banerjee, R, et al.
Published: (2014)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
by: Banerjee, R, et al.
Published: (2014)

POST-REPERFUSION LIVER BIOPSY AND ITS VALUE IN PREDICTING MORTALITY AND GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION
by: Marcos Vinícius ZANCHET, et al.
Published: (2016-09-01)

Multi-parametric MRI techniques for the non-invasive assessment of patients with liver disease
by: Pavlides, M
Published: (2015)

Comparison of Liver Biopsy with Hepascore in Patients with Hepatitis C-Genotype 1
by: Hamid Klantari, et al.
Published: (2011-06-01)

To perform or not to perform liver biopsy-that is the question.
by: Chapman, R
Published: (2002)

How to do it: Transjugular liver biopsy
by: Priyanka Gupta, et al.
Published: (2021-01-01)

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
by: Joo Hyun Oh, et al.
Published: (2023-04-01)